MTD Mettler-Toledo International
XNYS 1763.68 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
MTD
$1763.68
—
What changed
Recent filings, trades and movesKey stats
$1763.68
- 52-Week Range
- $1023.05 – $1806.58
- YTD
- +24.96%
- IV Rank (30D)
- 29.61
- Straddle Price
- $138.35
- P/C Vol Ratio
- 1.05
- Market Cap
- $34.5B
- Open
- $1743.80
- Day Range
- $1712.28 – $1768.88
- Volume
- 108,789
- Prev Close
- $1722.15
Fair Value
MODEL: SHORT
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 1.09 |
| Cost of Equity (CAPM) | 10.84% (VRP-adj) |
| WACC | 10.67% |
| Volatility Risk Premium | +12.1pp (IV − HV30), ERP adj +45bps |
| Effective Tax Rate | 17.5% |
| Rev. Growth (YoY, DCF input) | -0.2% |
| DCF Horizon | 12 years explicit + fade |
| Free Cash Flow (TTM) | $0.9B |
| Return on Equity (TTM) | 7062.4% |
| Book / Price | 0.0% |
| Gross Margin (TTM) | 60.3% |
| FCF Margin (TTM) | 20.9% |
| Debt / Equity | 159.45 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +22.4% (reverse-DCF on current price) |
| SMA 50 | $1524.02 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $1663.59 |
| Bollinger Width / SMA20 | 10.2% (drives anchor stability) |
| Net Debt | $2.0B |
| Market Cap | $35B |
Peers used for multiples: AAPL, AVGO, JNJ, LLY, MA, MSFT, NVDA, TMO
60-Day Conviction
61%
20-Day Fair Value
≈ by Dec 8, 2026
$1764.95
α -0.2%
rank 8%
conviction
16%
40-Day Fair Value
≈ by Jan 6, 2027
$1736.42
α -1.8%
rank 8%
conviction
60%
60-Day Fair Value
≈ by Feb 4, 2027
$1725.15
α -2.5%
rank 8%
conviction
61%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $356.49 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $1594.13 | 9% | median 35.9× · 8 peers |
| Peer EV/EBITDA | $1421.28 | 9% | median 23.5× · 8 peers |
| Peer P/B | $10.53 | 2% | median 16.6× · 8 peers |
| Peer P/S | $2618.74 | 6% | median 12.8× · 8 peers |
| Market Anchor (SMA50) | $1524.02 | 38% | stability 99% (BB-width) |
| Options Expected (B-L 30d) | $1742.05 | 19% | 63 strikes · skew +0.43 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNYS
- Market Cap
- $34.5B
- Employees
- 18,100
- List Date
- 1997-11-14
- CIK
- 0001037646
- Last Earnings
- Nov 5 after close · +2.6% vs ±8.3% expected
- Next Earnings
- ~Feb 4, 2027 (estimated)
- Headquarters
- Columbus, OH
- Homepage
- https://www.mt.com
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 0.62% | -12.07% | 4.86% | -1.40% | 11.77% | -2.70% | 0.18% |
| Feb | -5.49% | -5.86% | -8.13% | 1.90% | -5.19% | -1.37% | -4.02% |
| Mar | 1.85% | -1.45% | 7.92% | 4.99% | -6.92% | -4.82% | 0.26% |
| Apr | 11.75% | -6.86% | -2.55% | -8.31% | -7.42% | 0.20% | -2.20% |
| May | -1.12% | -0.53% | -12.99% | 12.35% | 9.36% | -6.83% | 0.04% |
| Jun | 6.87% | -9.07% | -1.33% | -0.13% | 2.94% | 7.94% | 1.20% |
| Jul | 6.70% | 16.17% | -4.17% | 11.28% | 2.36% | 8.67% | 6.83% |
| Aug | 4.91% | -10.24% | -5.52% | -5.03% | 8.67% | -2.76% | -1.66% |
| Sep | -11.29% | -10.28% | -9.36% | 7.27% | -3.79% | 9.81% | -2.94% |
| Oct | 6.55% | 11.61% | -9.39% | -12.58% | 9.81% | 13.07% | 3.18% |
| Nov | 4.82% | 14.73% | 12.63% | -6.77% | 4.96% | 5.40%* | 5.96% |
| Dec | 11.63% | -3.01% | 9.82% | -2.80% | -5.03% | -- | 2.12% |
| Total | 41.60% | -20.15% | -20.00% | -2.54% | 20.42% | 27.29% | 7.77% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1673.82
SMA 50: $1531.40
SMA 200: $1345.60
Current: $1767.54
EMA 12: $1697.07
EMA 26: $1643.56
MACD: 53.5131 | Signal: -0.8291
BULLISH
ADX (14): 42.86
STRONG TREND
+DI: 25.54
−DI: 12.62
Momentum Oscillators
RSI (14): 70.70
OVERBOUGHT
Stoch %K: 62.02
Stoch %D: 65.77
Williams %R: -19.47
Volume & Volatility
BB Upper: $1757.22
BB Lower: $1590.41
OVERBOUGHT
OBV: 4,165,029
Vol SMA 20: 207,066
Vol ROC: -15.97%
ATR: $50.90
True Range: $55.93
HV 20: 24.0%
HV 30: 24.4%
HV 60: 26.1%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before MTD’s Nov 5 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report
Executive Summary Overall assessment: NEUTRAL with confidence level (6/10)
Key drivers and primary risks:
- Technical indicators suggest a neutral to bullish trend, with MACD signal line crossover indicating potential upward momentum.
- News sentiment is positive, with recent headlines highlighting company directors' transactions, market trends, and research reports.
- Risk metrics indicate moderate volatility, with beta relative to the S&P 500 (0.81) suggesting a defensive stance.
Primary risks:
- Overbought RSI reading (38.72) could lead to short-term pullback or consolidation.
- Recent insider sales may suggest profit-taking or caution.
Investment thesis: MTD is experiencing a range-bound trend, with positive news sentiment and moderate volatility. While the stock has shown resilience, it remains vulnerable to market fluctuations and potential pullbacks.
Recent news sentiment impact: Positive headlines have contributed to the stock's recent stability, but it's essential to monitor any shifts in market narrative or catalysts that could influence MTD's performance.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Neutral
- Medium-term (1-3 months): Bullish
- Long-term (3-12 months): Neutral
Support/Resistance Levels: Upper: $1451.94, Middle: $1401.98, Lower: $1352.02
Momentum Signals:
- RSI interpretation: Neutral (38.72), with potential for short-term pullback or consolidation.
- MACD signal line crossover: Bullish momentum.
- Bollinger Bands position: Oversold.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines focus on company directors' transactions, market trends, and research reports.
Sentiment Assessment: Positive sentiment prevails, with 5 out of 6 recent headlines exhibiting a positive tone.
Catalyst Identification: Upcoming earnings release (no specific date available) may influence the stock's direction.
Market Narrative: Recent news highlights align with the bullish MACD signal line crossover, supporting a neutral to bullish trend assessment.
Risk & Volatility Assessment
Beta Interpretation: Moderate risk relative to the S&P 500 (beta: 0.81), suggesting a defensive stance.
Volatility Regime: Current volatility levels are moderate, consistent with historical averages.
Options Market Signals:
- IV rank: Medium (29.1%)
- Put/call ratios: Bullish (0.60)
Market Context & Positioning
Sector Performance: Pharmaceuticals sector has shown resilience, with a relatively stable performance compared to the broader market.
Institutional Activity: Volume patterns suggest institutional interest remains moderate, with no significant changes in recent activity.
Correlation Analysis: MTD's correlation with the S&P 500 is moderate (0.32), indicating a relatively defensive stance.
Relative Valuation: Position within trading range, with room for potential upside if news sentiment continues to support the stock.
Key Levels & Action Items
Critical Price Levels:
- Support: $1352.02
- Resistance: $1451.94
Breakout/Breakdown Levels:
- Short-term: $1401.98 (SMA 20)
- Medium-term: $1382.48 (EMA 12)
Time-Sensitive Catalysts: Upcoming earnings release (no specific date available) may influence the stock's direction.
Risk Management: Monitor for potential pullbacks or consolidations, and consider adjusting stop-loss levels accordingly.
This comprehensive analysis provides a detailed assessment of MTD's technical and fundamental performance. While the stock remains in a neutral to bullish trend, it's essential to monitor news sentiment and market narrative to identify potential catalysts or risks that could influence its direction.
Generated
News
All MTD news →
Asia strength and automation demand carried quarterly results, while Europe stays uncertain.
Earnings History
17 of 23 under expected move
Avg Expected Move
5.89%
Avg Actual Move
3.88%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-04 | After-Close | 6.19% | 1.79% | 0.29x | Within |
| 2021-05-06 | After-Close | 5.35% | 1.54% | 0.29x | Within |
| 2021-07-29 | After-Close | 5.09% | 2.51% | 0.49x | Within |
| 2021-11-04 | After-Close | 5.33% | 2.30% | 0.43x | Within |
| 2022-02-10 | After-Close | 5.88% | 6.00% | 1.02x | Exceeded |
| 2022-05-05 | After-Close | 5.99% | 0.35% | 0.06x | Within |
| 2022-07-28 | After-Close | 2.02% | 3.91% | 1.94x | Exceeded |
| 2022-11-03 | After-Close | 4.76% | 4.78% | 1.00x | Exceeded |
| 2023-02-09 | After-Close | 3.34% | 1.39% | 0.42x | Within |
| 2023-05-04 | After-Close | 6.55% | 3.40% | 0.52x | Within |
| 2023-07-27 | After-Close | 6.53% | 1.18% | 0.18x | Within |
| 2023-11-09 | After-Close | 5.93% | 1.91% | 0.32x | Within |
| 2024-01-04 | After-Close | 4.95% | 1.48% | 0.30x | Within |
| 2024-05-09 | After-Close | 5.10% | 17.04% | 3.34x | Exceeded |
| 2024-08-01 | After-Close | 6.64% | 4.88% | 0.73x | Within |
| 2024-11-07 | After-Close | 6.02% | 7.19% | 1.19x | Exceeded |
| 2025-05-01 | After-Close | 8.54% | 4.11% | 0.48x | Within |
| 2025-08-01 | After-Close | 4.51% | 2.89% | 0.64x | Within |
| 2025-11-06 | After-Close | 7.13% | 0.02% | 0.00x | Within |
| 2026-02-05 | After-Close | 7.35% | 0.67% | 0.09x | Within |
| 2026-05-07 | After-Close | 6.32% | 14.77% | 2.34x | Exceeded |
| 2026-07-30 | After-Close | 7.73% | 2.59% | 0.34x | Within |
| 2026-11-05 | After-Close | 8.30% | 2.57% | 0.31x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
MTD Options Activity & IV Rank
MTD IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 30.1%
7-DTE IV: 31.6%
Expected Move: $138.35
7-DTE Move: $78.25
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 1,265
Put Volume: 1,329
P/C Volume: 1.051
NEUTRAL
Call OI: 4,551
Put OI: 2,634
P/C OI: 0.579
Total OI: 7,185
ATM Options Pricing
ATM Call: $73.50
ATM Put: $64.85
Call %: 4.2%
Put %: 3.7%
Chain Summary
Chain Volume: 2,594
Chain OI: 7,185
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 78th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
78%
vs own history
GEX tilt
+0.68
OI-weighted, today
Vanna tilt
-0.09
δ-sensitivity to IV
Charm tilt
+0.05
δ-decay vs time
? What is this?
· 44 ATM contracts, 3k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)25.9MediumNov 9
IV Rank (30 DTE)29.6MediumNov 9
Straddle Price (30 DTE)$138.35Nov 9
Beta Analysis
Risk Metrics
Beta: 0.8101
Alpha: 15.73%
Correlation: 0.3510
R-Squared: 12.3%
Stock Volatility: 31.7%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
MTD Institutional Ownership (13F)
Filings for 2026-06-30 · 389 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 20,436,820 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
16 filers$462.68M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $125.58M | 27.14% | 2026-06-30 |
| 2 | UBS Group AG Custodian | $113.44M | 24.52% | 2026-06-30 |
| 3 | PEAK6 LLC | $84.32M | 18.22% | 2026-06-30 |
| 4 | Walleye Trading LLC | $26.96M | 5.83% | 2026-06-30 |
| 5 | Citadel Advisors LLC Custodian | $23.63M | 5.11% | 2026-06-30 |
| 6 | Twin Tree Management, LP | $18.40M | 3.98% | 2026-06-30 |
| 7 | Jane Street Group, LLC Custodian | $17.50M | 3.78% | 2026-06-30 |
| 8 | IMC-Chicago, LLC Custodian | $15.56M | 3.36% | 2026-09-30 |
| 9 | D. E. Shaw & Co., Inc. Custodian | $13.29M | 2.87% | 2026-06-30 |
| 10 | Royal Bank of Canada Custodian | $13.03M | 2.82% | 2026-06-30 |
| 11 | Squarepoint Ops LLC | $3.70M | 0.80% | 2026-06-30 |
| 12 | Simplex Trading, LLC Custodian | $2.42M | 0.52% | 2026-09-30 |
| 13 | Tidal Investments LLC | $2.17M | 0.47% | 2026-06-30 |
| 14 | TUDOR INVESTMENT CORP ET AL | $1.28M | 0.28% | 2026-06-30 |
| 15 | Millennium Management LLC Custodian | $1.15M | 0.25% | 2026-06-30 |
| 16 | Point72 Asset Management, L.P. | $255.50K | 0.06% | 2026-06-30 |
9 filers$58.70M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $19.03M | 32.43% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $11.03M | 18.79% | 2026-09-30 |
| 3 | Citadel Advisors LLC Custodian | $8.56M | 14.58% | 2026-06-30 |
| 4 | UBS Group AG Custodian | $7.67M | 13.06% | 2026-06-30 |
| 5 | Simplex Trading, LLC Custodian | $4.23M | 7.21% | 2026-09-30 |
| 6 | Walleye Trading LLC | $2.68M | 4.57% | 2026-06-30 |
| 7 | Jane Street Group, LLC Custodian | $2.68M | 4.57% | 2026-06-30 |
| 8 | Millennium Management LLC Custodian | $2.56M | 4.35% | 2026-06-30 |
| 9 | Point72 Asset Management, L.P. | $255.50K | 0.44% | 2026-06-30 |
MTD Insider Trading (Form 4)
Latest: 2026-09-01Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Natalia Shuman-Fabbri | Director | Award (A) | +16 | — | EDGAR | |
| 2026-08-31 | Patrick Kaltenbach | President and CEO | Mixed Exer +942 · Sell −942 |
— | $1224.78 | -$377.2K | EDGAR |
| 2026-08-07 | Thomas P Salice | Director | Mixed Exer +417 · Sell −417 |
— | $919.18 | -$434.7K | EDGAR |
| 2026-08-05 | Shawn Vadala | Chief Financial Officer | Mixed Exer +2,240 · Sell −2,240 |
— | $1013.66 | -$1.87M | EDGAR |
| 2026-08-05 | Thomas P Salice | Director | Mixed Sell −415 · Exer +415 |
— | $921.28 | -$434.4K | EDGAR |
| 2026-08-05 | Gerry Keller | Head of Process Analytics | Mixed Sell −240 · Exer +240 |
— | $1073.97 | -$169.5K | EDGAR |
| 2026-05-14 | Susan Graham-Bryce | Chief Human Resources Officer | Award (A) | +71 | — | EDGAR | |
| 2026-05-14 | Patrick Kaltenbach | President and CEO | Award (A) | +810 | — | EDGAR | |
| 2026-05-14 | Gerry Keller | Head of Process Analytics | Award (A) | +100 | — | EDGAR | |
| 2026-05-14 | Shawn Vadala | Chief Financial Officer | Award (A) | +291 | — | EDGAR | |
| 2026-05-14 | Oliver Wittorf | Head of PI, Retail, and GSC | Award (A) | +87 | — | EDGAR | |
| 2026-05-14 | Ann Ping Richard Wong | Head of Asia & Pacific | Award (A) | +103 | — | EDGAR | |
| 2026-02-19 | Michael J Tokich | Director | Award (A) | +50 | — | EDGAR | |
| 2026-02-11 | Shawn Vadala | Chief Financial Officer | Mixed Sell −800 · Exer +800 |
— | $1002.72 | -$651.8K | EDGAR |
| 2025-11-26 | Shawn Vadala | Chief Financial Officer | Mixed Sell −2,025 · Exer +2,025 |
— | $1057.53 | -$1.72M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
MTD Insider Holdings
20 insiders · @ $1767.54
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Thomas P Salice | Director | 33,357 | $58.96M | -$65.64M | 65 | 2026-08-07 |
| 2 | Shawn Vadala | Chief Financial Officer | 5,579 | $9.86M | -$40.59M | 57 | 2026-08-05 |
| 3 | Patrick Kaltenbach | President and CEO | 4,480 | $7.92M | -$4.21M | 13 | 2026-08-31 |
| 4 | Guerroniere Marc de la | Head of Eur & NA Market Orgs | 3,767 | $6.66M | -$103.74M | 49 | 2025-11-26 |
| 5 | Michael A Kelly | Director | 1,811 | $3.20M | -$13.55M | 25 | 2025-11-13 |
| 6 | Christian Magloth | Head of Human Resources | 734 | $1.30M | -$30.05M | 44 | 2025-02-26 |
| 7 | Roland D Diggelmann | Director | 732 | $1.29M | $323.4K | 5 | 2025-11-13 |
| 8 | Ann Ping Richard Wong | Head of Asia & Pacific | 645 | $1.14M | -$1.90M | 8 | 2026-05-14 |
| 9 | Richard D Francis | Director | 624 | $1.10M | $100.5K | 10 | 2024-11-14 |
| 10 | Susan Graham-Bryce | Chief Human Resources Officer | 517 | $913.8K | $0 | 3 | 2026-05-14 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
MTD Board & Officers
As of SEC filings through Sep 1, 2026Directors 11
- Thomas P Salice · on file since 2006
- Michael A Kelly · since Jul 24, 2008
- Elisha W Finney · since Nov 1, 2017
- Bigot Domitille Doat-Le · since Feb 1, 2020
- Roland D Diggelmann · since Aug 1, 2022
- Ingrid Zhang · since Feb 1, 2023
- Wolfgang Wienand · since Nov 1, 2023
- Brian A Shepherd · since Jul 2, 2024
- Pablo Perversi · since Nov 6, 2025
- Michael J Tokich · since Feb 5, 2026
- Natalia Shuman-Fabbri · since Aug 3, 2026
Officers 7
- Patrick Kaltenbach · President and CEO · listed since Apr 2021
- Shawn Vadala · Chief Financial Officer · since Jan 3, 2014
- Susan Graham-Bryce · Chief Human Resources Officer · since Apr 1, 2025
- Guerroniere Marc de la · Head of Eur & NA Market Orgs. · listed since Nov 2014
- Gerry Keller · Head of Process Analytics · since Jul 26, 2018
- Ann Ping Richard Wong · Head of Asia & Pacific · listed since Nov 2024
- Oliver Wittorf · Head of PI, Retail, and GSC · since Jan 1, 2026
Changes in the last 10 years (28)
| Aug 3, 2026 | Natalia Shuman-Fabbri became a director |
| Feb 5, 2026 | Michael J Tokich became a director |
| Jan 1, 2026 | Oliver Wittorf became Head of PI, Retail, and GSC |
| Nov 6, 2025 | Pablo Perversi became a director |
| Apr 1, 2025 | Susan Graham-Bryce became Chief Human Resources Officer |
| Nov 14, 2024 | Ann Ping Richard Wong listed as Head of Asia & Pacific (previously Head of Asia/Pac Market Orgs) in SEC filings |
| Jul 2, 2024 | Brian A Shepherd became a director |
| Dec 14, 2023 | The company announced the departure of Robert F Spoerry from the board in an SEC filing |
| Nov 1, 2023 | Wolfgang Wienand became a director |
| Feb 1, 2023 | Ingrid Zhang became a director |
| Dec 19, 2022 | Ann Ping Richard Wong became Head of Asia/Pac Market Orgs |
| Nov 21, 2022 | The company announced the departure of Olivier A Filliol from the board in an SEC filing |
| Nov 8, 2022 | The company announced the departure of Wah-Hui Chu from the board in an SEC filing |
| Aug 1, 2022 | Roland D Diggelmann became a director |
| Feb 22, 2022 | The company announced the departure of Peter Aggersbjerg as Head of Divisions in an SEC filing |
| Feb 17, 2022 | Peter Aggersbjerg listed as Head of Divisions (previously Head of Divisions & Operations) in SEC filings |
| Nov 8, 2021 | Peter Aggersbjerg listed as Head of Divisions & Operations (previously Head of Laboratory) in SEC filings |
| May 21, 2021 | Olivier A Filliol no longer listed as President and CEO in SEC filings |
| Apr 5, 2021 | Patrick Kaltenbach listed as President and CEO (previously CEO Designate) in SEC filings |
| Jan 25, 2021 | Patrick Kaltenbach became CEO Designate |
| Feb 1, 2020 | Bigot Domitille Doat-Le became a director |
| May 9, 2019 | Marco Gadola became a director |
| Jan 31, 2019 | William P Donnelly reported in an SEC filing no longer being Executive Vice President |
| Nov 13, 2018 | Gerry Keller no longer listed as a director in SEC filings |
| Jul 26, 2018 | Gerry Keller became a director |
| Jul 26, 2018 | Gerry Keller became Head of Process Analytics |
| Feb 8, 2018 | Peter Aggersbjerg became Head of Laboratory |
| Nov 1, 2017 | Elisha W Finney became a director |
Not reported recently (10)
- Christian Magloth · Last reported as Head of Human Resources in an SEC filing dated Feb 26, 2025
- Richard D Francis · Last reported as a director in an SEC filing dated Nov 14, 2024
- Simon Kirk · Last reported as Head of Product Inspection in an SEC filing dated Dec 6, 2019
- Michael Heidingsfelder · Last reported as Head of Industrial in an SEC filing dated Nov 21, 2019
- Marco Gadola · Last reported as a director in an SEC filing dated Nov 12, 2019
- Hans Ulrich Maerki · Last reported as a director in an SEC filing dated Feb 22, 2019
- Connie L Harvey · Last reported as a director in an SEC filing dated Feb 19, 2019
- Waldemar Rauch · Last reported as Head of Process Analytics in an SEC filing dated Mar 12, 2018
- Francis A Contino · Last reported as a director in an SEC filing dated Feb 26, 2018
- Thomas Caratsch · Last reported as Head of Laboratory in an SEC filing dated Nov 29, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
MTD Proposed Insider Sales (Form 144)
Latest: 2026-08-05
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Thomas Salice | Director | 417 | $600.7K | 2026-08-05 | Merrill | — | EDGAR |
| 2026-08-03 | Thomas Salice | Board of Director | 415 | $599.5K | 2026-08-03 | Merrill | — | EDGAR |
| 2026-07-28 | Michael Kelly | Former Director | 832 | $1.15M | 2026-07-28 | Merrill | — | EDGAR |
| 2025-11-10 | Elisha Finney | Board of Director | 474 | $679.5K | 2025-11-10 | Merrill | — | EDGAR |
| 2025-08-13 | SALICE THOMAS P | Director | 1,062 | $1.38M | 2025-08-13 | Merrill | — | EDGAR |
| 2025-05-28 | Kelly Michael A | Director | 1,062 | $1.23M | 2025-05-28 | Merill | — | EDGAR |
| 2024-11-12 | FINNEY ELISHA W | Officer | 76 | $99.7K | 2024-11-11 | Merrill Lynch | — | EDGAR |
| 2024-05-13 | SALICE THOMAS P | Director | 1,268 | $1.89M | 2024-05-13 | Merrill | — | EDGAR |
| 2024-05-13 | SPOERRY ROBERT F | Former Director | 5,085 | $7.50M | 2024-05-13 | Merrill | — | EDGAR |
| 2024-02-12 | Kelly Michael A | Director | 1,268 | $1.49M | 2024-02-12 | Merill | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-06
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-05 | Earnings results | EDGAR |
| 2026-08-03 | Director or officer change · Regulation FD disclosure | EDGAR |
| 2026-07-30 | Earnings results | EDGAR |
| 2026-05-13 | Director or officer change | EDGAR |
| 2026-05-11 | Shareholder vote results | EDGAR |
| 2026-05-07 | Earnings results | EDGAR |
| 2026-02-05 | Earnings results | EDGAR |
| 2026-01-20 | Director or officer change · Regulation FD disclosure | EDGAR |
| 2025-11-06 | Earnings results | EDGAR |
| 2025-10-23 | Director or officer change | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-06 | 0001037646-26-000011 | EDGAR |
| 2025-02-07 | 0001037646-25-000012 | EDGAR |
| 2024-02-09 | 0001037646-24-000007 | EDGAR |
| 2023-02-10 | 0001037646-23-000005 | EDGAR |
| 2022-02-11 | 0001037646-22-000008 | EDGAR |
| 2021-02-08 | 0001037646-21-000008 | EDGAR |
| 2020-02-07 | 0001037646-20-000005 | EDGAR |
| 2019-02-08 | 0001037646-19-000010 | EDGAR |
| 2018-02-09 | 0001037646-18-000006 | EDGAR |
| 2017-02-02 | 0001037646-17-000004 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-11-06 | 0001037646-26-000074 | EDGAR |
| 2026-07-31 | 0001037646-26-000051 | EDGAR |
| 2026-05-08 | 0001037646-26-000021 | EDGAR |
| 2025-11-07 | 0001037646-25-000058 | EDGAR |
| 2025-08-01 | 0001037646-25-000040 | EDGAR |
| 2025-05-02 | 0001037646-25-000021 | EDGAR |
| 2024-11-08 | 0001037646-24-000034 | EDGAR |
| 2024-08-02 | 0001037646-24-000027 | EDGAR |
| 2024-05-10 | 0001037646-24-000012 | EDGAR |
| 2023-11-09 | 0001037646-23-000035 | EDGAR |
ETF Holders
261 ETFs hold MTD
25 shown · $5.46B total exposure · 0.08% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.04% | $960.5M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.05% | $796.8M | — | 2026-09-30 |
| 3 | VO Vanguard Morningstar Mid-Cap ETF | Vanguard | 0.30% | $648.3M | — | 2026-09-30 |
| 4 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.05% | $463.9M | $852.9B | 2026-11-06 |
| 5 | VUG Vanguard Morningstar Growth ETF | Vanguard | 0.11% | $426.3M | — | 2026-09-30 |
| 6 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.05% | $410.7M | $777.7B | 2026-11-05 |
| 7 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.26% | $261.6M | — | 2026-11-05 |
| 8 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.50% | $250.5M | $49.9B | 2026-11-05 |
| 9 | VOT Vanguard Morningstar Mid-Cap Growth ETF | Vanguard | 0.72% | $237.7M | — | 2026-09-30 |
| 10 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.26% | $147.2M | $56.9B | 2026-11-06 |
| 11 | CGGR Capital Group Growth ETF | Capitalgroup | 0.54% | $132.9M | $24.7B | 2026-11-05 |
| 12 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.05% | $94.0M | $177.9B | 2026-11-05 |
| 13 | VHT Vanguard Health Care ETF | Vanguard | 0.43% | $93.3M | — | 2026-09-30 |
| 14 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.09% | $76.3M | $82.9B | 2026-11-06 |
| 15 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.11% | $68.9M | — | 2026-08-31 |
| 16 | GSLC Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF | Goldman | 0.36% | $52.7M | $14.6B | 2026-11-05 |
| 17 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.34% | $49.4M | $14.8B | 2026-11-06 |
| 18 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.05% | $45.1M | $93.2B | 2026-11-06 |
| 19 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.05% | $42.8M | — | 2026-11-05 |
| 20 | ESGU iShares ESG Aware MSCI USA ETF | iShares (BlackRock) | 0.23% | $39.9M | $17.3B | 2026-11-06 |
| 21 | VV Vanguard Morningstar Large-Cap ETF | Vanguard | 0.05% | $35.6M | — | 2026-09-30 |
| 22 | IVW iShares S&P 500 Growth ETF | iShares (BlackRock) | 0.05% | $34.6M | $71.7B | 2026-11-06 |
| 23 | JQUA JPMorgan U.S. Quality Factor ETF | JPMorgan | 0.35% | $33.1M | $9.5B | 2026-11-06 |
| 24 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.06% | $30.8M | $50.4B | 2026-11-06 |
| 25 | SCHX Schwab U.S. Large-Cap ETF | Nport | 0.04% | $30.2M | — | 2026-08-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
39.86
TTM Diluted EPS
$44.38
TTM Revenue
$4.13B
TTM Net Income
$905.61M
TTM Op. Cash Flow
$975.17M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $1.03B | $232.90M | $11.55 | $310.42M |
| Q1 '26 | 2026-03-31 | $947.13M | $169.45M | $8.33 | $139.79M |
| Q4 '25 | 2025-12-31 | $1.13B | $285.76M | $13.93 | $225.59M |
| Q3 '25 | 2025-09-30 | $1.03B | $217.49M | $10.57 | $299.37M |
| Q2 '25 | 2025-06-30 | $983.22M | $202.35M | $9.76 | $236.37M |
| Q1 '25 | 2025-03-31 | $883.74M | $163.59M | $7.81 | $194.45M |
| Q4 '24 | 2024-12-31 | $1.05B | $252.30M | $11.93 | $266.19M |
| Q3 '24 | 2024-09-30 | $954.53M | $211.52M | $9.96 | $254.67M |
| Q2 '24 | 2024-06-30 | $946.75M | $221.81M | $10.37 | $257.51M |
| Q1 '24 | 2024-03-31 | $925.95M | $177.51M | $8.24 | $189.99M |
| Q4 '23 | 2023-12-31 | $934.99M | $184.79M | $8.53 | $281.50M |
| Q3 '23 | 2023-09-30 | $942.46M | $201.63M | $9.21 | $264.30M |
Q2 2026 • period ending 2026-06-30 • filed 2026-07-31
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
39.86
P/B
2819.17
P/S
8.74
EV/EBITDA
29.22
EV/Sales
9.23
ROE
7062.4%
ROA
24.7%
Div Yield
0.00%
FCF Yield
2.70%
Debt/Equity
159.45
Current Ratio
—
Market Cap
$36.15B
as of 2026-11-09
MTD vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AAPL Apple Inc. | $4.98T | 39.2 | +15.1% | +29.7% | 16 |
| NVDA Nvidia Corp | $4.51T | 22.2 | +83.4% | −6.8% | 87 |
| MSFT Microsoft Corp | $3.94T | 28.5 | +17.9% | +15.3% | 11 |
| AVGO Broadcom Inc. Common Stock | $1.40T | 40.7 | +48.7% | −8.3% | 81 |
| LLY Eli Lilly & Co. | $1.21T | 45.9 | +45.5% | +31.0% | 27 |
| JNJ Johnson & Johnson | $664.9B | 42.8 | +7.8% | +36.0% | 58 |
| MA Mastercard Incorporated | $568.6B | 34.4 | +15.3% | +16.8% | 28 |
| TMO Thermo Fisher Scientific, Inc. | $257.4B | 37.7 | +8.3% | +20.6% | 46 |
| MTD Mettler-Toledo International | $34.5B | 39.8 | +6.9% | +25.2% | 30 |
| Peer median | $1.30T | 38.5 | +16.6% | +18.7% | 37 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
657.65K
SI % of Float
3.27%
Days to Cover
3.13
Short Vol Ratio
65.3%
Free Float
20.11M
Float %
99.3%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-03-09